Clinical Trials Directory

Trials / Unknown

UnknownNCT01949922

Treatment of Fecal Incontinence by Injection of Autologous Muscle Fibers Into the Anal Sphincter

Treatment of Fecal Incontinence by Injection of Autologous Muscle Fibers Into the Anal Sphincter - a Pilot Study.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Herlev Hospital · Academic / Other
Sex
Female
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Aim: To investigate efficacy and safety in a new treatment with injection of autologous muscle fibers into the anal sphincter in patients with fecal incontinence. Method: Patients with fecal incontinence after obstetric anal sphincter rupture will be included. After inclusion, they will be offered 3 months of pelvic floor muscle training. If the patients after completion of pelvic floor muscle training still suffer from fecal incontinence, the patients will be offered treatment with autologous muscle fiber injection into the anal sphincter. The patients will be followed one year after the injection. The autologous muscle fibers are harvested at the patients leg muscle, cut into small pieces and injected into the anal sphincter. A small part of the fibers are used for analysing number of muscle stem cells and thereby the regenerative potential of the sample. The study is a pilot study.

Conditions

Interventions

TypeNameDescription
PROCEDUREInjection of autologous muscle fibers into the anal sphincter.
PROCEDUREPelvic floor muscle trainingPelvic floor muscle training 3 months to optimize pelvic floor muscle function. Autologous muscle stem cell injection will only be offered to patients that still have problems after completion of pelvic floor muscle training.
BEHAVIORALDietary interventionDietary intervention 3 months to optimize defecatory function. Autologous muscle stem cell injection will only be offered to patients that still have problems after completion of pelvic floor muscle training and dietary intervention.
DRUGAnalgesiaPatients will be offered analgesia as needed during and after surgery. Specific products will depend on allergy and preferences of doctors involved and patient's requirements.

Timeline

Start date
2013-04-01
Primary completion
2017-01-01
Completion
2018-01-01
First posted
2013-09-25
Last updated
2016-02-19

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01949922. Inclusion in this directory is not an endorsement.